Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey John Popma, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Popma and Thomas Gleason.
Connection Strength

2.755
  1. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):85-96.
    View in: PubMed
    Score: 0.654
  2. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 05 02; 380(18):1706-1715.
    View in: PubMed
    Score: 0.202
  3. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol. 2018 12 04; 72(22):2687-2696.
    View in: PubMed
    Score: 0.195
  4. Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. Ann Thorac Surg. 2018 Feb; 105(2):477-483.
    View in: PubMed
    Score: 0.183
  5. Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. JAMA Cardiol. 2016 11 01; 1(8):945-949.
    View in: PubMed
    Score: 0.171
  6. Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation. JACC Cardiovasc Imaging. 2016 08; 9(8):973-81.
    View in: PubMed
    Score: 0.168
  7. Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2016 07; 9(7).
    View in: PubMed
    Score: 0.167
  8. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015 Jul 14; 66(2):113-21.
    View in: PubMed
    Score: 0.155
  9. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20; 63(19):1972-81.
    View in: PubMed
    Score: 0.143
  10. The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve Replacement. Ann Thorac Surg. 2021 09; 112(3):778-785.
    View in: PubMed
    Score: 0.057
  11. Computed Tomography Annular Dimensions: A Novel Method to Compare Prosthetic Valve Hemodynamics. Ann Thorac Surg. 2020 11; 110(5):1502-1510.
    View in: PubMed
    Score: 0.054
  12. Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch. Circ Cardiovasc Interv. 2019 04; 12(4):e007396.
    View in: PubMed
    Score: 0.051
  13. Causes of death in intermediate-risk patients: The Randomized Surgical Replacement and Transcatheter Aortic Valve Implantation Trial. J Thorac Cardiovasc Surg. 2019 09; 158(3):718-728.e3.
    View in: PubMed
    Score: 0.049
  14. Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients. J Am Coll Cardiol. 2018 10 30; 72(18):2109-2119.
    View in: PubMed
    Score: 0.049
  15. Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery. J Thorac Cardiovasc Surg. 2018 05; 155(5):1991-1999.
    View in: PubMed
    Score: 0.047
  16. Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2018 04; 105(4):1129-1136.
    View in: PubMed
    Score: 0.046
  17. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement. Semin Thorac Cardiovasc Surg. 2017 Autumn; 29(3):321-330.
    View in: PubMed
    Score: 0.045
  18. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 04 06; 376(14):1321-1331.
    View in: PubMed
    Score: 0.044
  19. Causes of death from the randomized CoreValve US Pivotal High-Risk Trial. J Thorac Cardiovasc Surg. 2017 06; 153(6):1293-1301.e1.
    View in: PubMed
    Score: 0.044
  20. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jun 07; 67(22):2565-74.
    View in: PubMed
    Score: 0.041
  21. Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1014-22, 1023.e1-3.
    View in: PubMed
    Score: 0.040
  22. Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. Ann Thorac Surg. 2016 Jan; 101(1):72-9; discussion 79.
    View in: PubMed
    Score: 0.040
  23. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. J Am Coll Cardiol. 2015 Sep 22; 66(12):1327-34.
    View in: PubMed
    Score: 0.040
  24. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2869-76.e1-7.
    View in: PubMed
    Score: 0.037
  25. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 08; 370(19):1790-8.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.